Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CE-224,535 in rheumatoid arthritis
NCT00628095Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of CE-224535 in rheumatoid arthritis (RA), sponsored by Pfizer. Started Apr 2008; status: completed.
02
Drugs
CE-224535
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00628095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628095.